In the realm of immunodiagnostics, antibodies have long been invaluable tools, enabling the detection and measurement of various molecules with high specificity and sensitivity. Their significance in ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

The human immune system must respond to a diverse array of infectious agents and harmful invaders throughout our lifetime. To do so, the genes that are responsible for creating antibodies can undergo ...

Immunovant (NASDAQ:IMVT) advances autoimmune research as nasdaq today reflects activity across clinical-stage biotech ...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) and argenx (Euronext & Nasdaq: ARGX) announced today that Genmab and argenx have entered into a collaboration agreement to jointly ...

Having kicked off the year with a $200 million series A, Windward Bio is ending 2025 splashing out on another clinical-stage drug. | Having kicked off the year with a $200 million series A, Windward ...

The MarketWatch News Department was not involved in the creation of this content.-- Windward Bio and Qyuns Therapeutics announce licensing agreement for WIN027, a highly potent, l ...

Biogen is placing a $1.15 billion bet on Chris Viehbacher’s diversification vision. The upfront payment has secured Biogen a deal to buy Human Immunology Biosciences (HI-Bio), a biotech that is ...

Johnson & Johnson is building up its immunology pipeline, striking a $1.25 billion deal for a bispecific antibody in development for atopic dermatitis — its second acquisition agreement in the ...

AbbVie announced Thursday that it has acquired DJS Antibodies in a move to expand its immunology portfolio. Through the transaction, the pharma company adds DJS-002, DJS’ lead product candidate and a ...

Explore eight major immunology and inflammation (I&I) partnerships in 2025, from early-stage research to late-stage licensing ...